| 1 | [SID863620] | Active | Potency | 9.2 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 2 | [SID863620] | Active | Potency | 10.4179 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 10.4179 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID863620] | Active | Potency | 12.5893 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 4 | [SID863620] | Active | Potency | 12.5893 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 5 | [SID24840933] | Active | Potency | 12.9953 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID24840933] | Active | Potency | 12.9953 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID24840933] | Active | Potency | 12.9953 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID24840933] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID24840933] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID24840933] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID863620] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2517 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 12 | [SID863620] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 13 | [SID863620] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 14 | [SID863620] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 15 | [SID863620] | Active | Potency | 35.4813 | qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent) [AID485294, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent) | | AID | 485294 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 16 | [SID863620] | Active | IC50 | 36.83 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | IC50 | 36.83 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 17 | [SID863620] | Active | IC50 | 40.16 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme [AID624351, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | IC50 | 40.16 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme | | AID | 624351 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID863620] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 19 | [SID863620] | Active | | | uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay [AID651699, Type: screening] | NAE1 gene product [Homo sapiens] [gi:4502169] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay | | AID | 651699 | | BioAssay type | screening | | Target | NAE1 gene product [Homo sapiens] [gi:4502169] | | PubMed | | | Data Table |  |
|
| 20 | [SID863620] | Active | | | Single concentration confirmation of uHTS hits for Peg3 Promoter Inhibitors via a luciferase reporter assay [AID602417, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for Peg3 Promoter Inhibitors via a luciferase reporter assay | | AID | 602417 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 21 | [SID863620] | Active | | | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme [AID2563, Type: screening] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme | | AID | 2563 | | BioAssay type | screening | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 22 | [SID863620] | Active | | | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme [AID2563, Type: screening] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme | | AID | 2563 | | BioAssay type | screening | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 23 | [SID863620] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 24 | [SID863620] | Active | | | Epi-absorbance-based confirmation assay for common VIM-2 and IMP-1 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase. [AID2187, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Epi-absorbance-based confirmation assay for common VIM-2 and IMP-1 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase. | | AID | 2187 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 25 | [SID863620] | Active | | | Epi-absorbance-based confirmation assay for common VIM-2 and IMP-1 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase. [AID2187, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Epi-absorbance-based confirmation assay for common VIM-2 and IMP-1 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase. | | AID | 2187 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 26 | [SID863620] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 27 | [SID863620] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 28 | [SID24840933] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 29 | [SID24840933] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 30 | [SID24840933] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 31 | [SID24840933] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 32 | [SID863620] | Active | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 33 | [SID863620] | Active | EC50 | | Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells) [AID431, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | EC50 | [uM] | | BioAssay | Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells) | | AID | 431 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID863620] | Active | | | Cell signaling CRE-BLA (Fsk stim) [AID662, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Cell signaling CRE-BLA (Fsk stim) | | AID | 662 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID863620] | Active | IC50 | | HCS for Compounds that Down-Regulate Insulin Promoter Activity in MIN6 Cells [AID1628, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | IC50 | [uM] | | BioAssay | HCS for Compounds that Down-Regulate Insulin Promoter Activity in MIN6 Cells | | AID | 1628 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID863620] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 37 | [SID863620] | Active | | | HTS for Estrogen Receptor-beta Coactivator Binding inhibitors [AID633, Type: screening] | estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | HTS for Estrogen Receptor-beta Coactivator Binding inhibitors | | AID | 633 | | BioAssay type | screening | | Target | estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013] | | PubMed | | | Data Table |  |
|
| 38 | [SID863620] | Active | | | HTS for Estrogen Receptor-beta Coactivator Binding inhibitors [AID633, Type: screening] | estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | HTS for Estrogen Receptor-beta Coactivator Binding inhibitors | | AID | 633 | | BioAssay type | screening | | Target | estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013] | | PubMed | | | Data Table |  |
|
| 39 | [SID863620] | Active | | | HTS for Estrogen Receptor-beta Coactivator Binding inhibitors [AID633, Type: screening] | estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | HTS for Estrogen Receptor-beta Coactivator Binding inhibitors | | AID | 633 | | BioAssay type | screening | | Target | estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013] | | PubMed | | | Data Table |  |
|
| 40 | [SID863620] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID522, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 522 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 41 | [SID863620] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID522, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 522 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 42 | [SID863620] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID522, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 522 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 43 | [SID863620] | Active | | | qHTS Assay for Tau Filament Binding [AID596, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | qHTS Assay for Tau Filament Binding | | AID | 596 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 44 | [SID863620] | Active | | | qHTS Assay for Tau Filament Binding [AID596, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | qHTS Assay for Tau Filament Binding | | AID | 596 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 45 | [SID863620] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 46 | [SID863620] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 47 | [SID863620] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 48 | [SID24840933] | Active | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24840933 | | CID | 6603603 | | Outcome | Active | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 49 | [SID863620] | Active | | | Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E) [AID571, Type: screening] | 5-hydroxytryptamine receptor 1E [gi:112822] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E) | | AID | 571 | | BioAssay type | screening | | Target | 5-hydroxytryptamine receptor 1E [gi:112822] | | PubMed | | | Data Table |  |
|
| 50 | [SID863620] | Active | | | Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E) [AID571, Type: screening] | 5-hydroxytryptamine receptor 1E [gi:112822] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 863620 | | CID | 6603603 | | Outcome | Active | | BioAssay | Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E) | | AID | 571 | | BioAssay type | screening | | Target | 5-hydroxytryptamine receptor 1E [gi:112822] | | PubMed | | | Data Table |  |
|